skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:049246/0785   Pages: 5
Recorded: 05/21/2019
Attorney Dkt #:048500-999
Conveyance: CHANGE OF ASSIGNEE ADDRESS
Total properties: 36
1
Patent #:
7267968
Issue Dt:
09/11/2007
Application #:
10512746
Filing Dt:
10/27/2004
Publication #:
US20050164358
Pub Dt:
07/28/2005
Title:
MICROBIAL N-AND O-DEMETHYLATION OF A THEBAINE DERIVATIVE
2
Patent #:
8852638
Issue Dt:
10/07/2014
Application #:
11535398
Filing Dt:
09/26/2006
Publication #:
US20070077304
Pub Dt:
04/05/2007
Title:
Sustained Release Small Molecule Drug Formulation
3
Patent #:
10010612
Issue Dt:
07/03/2018
Application #:
12602058
Filing Dt:
06/30/2010
Publication #:
US20100266655
Pub Dt:
10/21/2010
Title:
SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUNDS
4
Patent #:
8697718
Issue Dt:
04/15/2014
Application #:
12664285
Filing Dt:
07/06/2010
Publication #:
US20100292265
Pub Dt:
11/18/2010
Title:
PACK OF MEDICINAL TABLETS
5
Patent #:
9486531
Issue Dt:
11/08/2016
Application #:
12995956
Filing Dt:
02/22/2011
Publication #:
US20110171305
Pub Dt:
07/14/2011
Title:
DEHYDRATED HYDROGEL INCLUSION COMPLEX OF A BIOACTIVE AGENT WITH FLOWABLE DRUG DELIVERY SYSTEM
6
Patent #:
8921387
Issue Dt:
12/30/2014
Application #:
13703013
Filing Dt:
01/27/2013
Publication #:
US20130210853
Pub Dt:
08/15/2013
Title:
Injectable Flowable Composition Comprising Buprenorphine
7
Patent #:
9295645
Issue Dt:
03/29/2016
Application #:
13703015
Filing Dt:
02/05/2013
Publication #:
US20130202658
Pub Dt:
08/08/2013
Title:
Compositions Comprising Buprenorphine
8
Patent #:
9044450
Issue Dt:
06/02/2015
Application #:
13790930
Filing Dt:
03/08/2013
Publication #:
US20140086990
Pub Dt:
03/27/2014
Title:
SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
9
Patent #:
8975270
Issue Dt:
03/10/2015
Application #:
13836134
Filing Dt:
03/15/2013
Publication #:
US20130203796
Pub Dt:
08/08/2013
Title:
INJECTABLE FLOWABLE COMPOSITION COMPRISING BUPRENORPHINE
10
Patent #:
9180197
Issue Dt:
11/10/2015
Application #:
14490034
Filing Dt:
09/18/2014
Publication #:
US20150099767
Pub Dt:
04/09/2015
Title:
SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUNDS
11
Patent #:
9186413
Issue Dt:
11/17/2015
Application #:
14490082
Filing Dt:
09/18/2014
Publication #:
US20150005323
Pub Dt:
01/01/2015
Title:
SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUNDS
12
Patent #:
9272044
Issue Dt:
03/01/2016
Application #:
14610818
Filing Dt:
01/30/2015
Publication #:
US20150216988
Pub Dt:
08/06/2015
Title:
INJECTABLE FLOWABLE COMPOSITION BUPRENORPHINE
13
Patent #:
9597402
Issue Dt:
03/21/2017
Application #:
14701173
Filing Dt:
04/30/2015
Publication #:
US20150231258
Pub Dt:
08/20/2015
Title:
SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
14
Patent #:
9687454
Issue Dt:
06/27/2017
Application #:
14989669
Filing Dt:
01/06/2016
Publication #:
US20160113885
Pub Dt:
04/28/2016
Title:
SUBLINGUAL AND BUCCAL FILM COMPOSITIONS
15
Patent #:
9498432
Issue Dt:
11/22/2016
Application #:
14995053
Filing Dt:
01/13/2016
Publication #:
US20160128934
Pub Dt:
05/12/2016
Title:
INJECTABLE FLOWABLE COMPOSITION COMPRISING BUPRENORPHINE
16
Patent #:
10172849
Issue Dt:
01/08/2019
Application #:
15060184
Filing Dt:
03/03/2016
Publication #:
US20160184296
Pub Dt:
06/30/2016
Title:
COMPOSITIONS COMPRISING BUPRENORPHINE
17
Patent #:
10022367
Issue Dt:
07/17/2018
Application #:
15125052
Filing Dt:
09/09/2016
Publication #:
US20170079974
Pub Dt:
03/23/2017
Title:
SUSTAINED-RELEASE BUPRENORPHINE SOLUTIONS
18
Patent #:
10149912
Issue Dt:
12/11/2018
Application #:
15295630
Filing Dt:
10/17/2016
Publication #:
US20170035895
Pub Dt:
02/09/2017
Title:
DEHYDRATED HYDROGEL INCLUSION COMPLEX
19
Patent #:
9782402
Issue Dt:
10/10/2017
Application #:
15334000
Filing Dt:
10/25/2016
Publication #:
US20170079976
Pub Dt:
03/23/2017
Title:
INJECTABLE COMPOSITION COMPRISING BUPRENORPHINE
20
Patent #:
10058554
Issue Dt:
08/28/2018
Application #:
15422626
Filing Dt:
02/02/2017
Publication #:
US20170239252
Pub Dt:
08/24/2017
Title:
SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
21
Patent #:
NONE
Issue Dt:
Application #:
15483769
Filing Dt:
04/10/2017
Publication #:
US20170209431
Pub Dt:
07/27/2017
Title:
SUBLINGUAL AND BUCCAL FILM COMPOSITIONS
22
Patent #:
10000477
Issue Dt:
06/19/2018
Application #:
15522863
Filing Dt:
04/28/2017
Publication #:
US20170334895
Pub Dt:
11/23/2017
Title:
DOPAMINE D3 RECEPTOR ANTAGONIST COMPOUNDS
23
Patent #:
11000520
Issue Dt:
05/11/2021
Application #:
15523986
Filing Dt:
05/03/2017
Publication #:
US20170354653
Pub Dt:
12/14/2017
Title:
BUPRENORPHINE DOSING REGIMENS
24
Patent #:
9827241
Issue Dt:
11/28/2017
Application #:
15623191
Filing Dt:
06/14/2017
Publication #:
US20170281618
Pub Dt:
10/05/2017
Title:
INJECTABLE FLOWABLE COMPOSITION COMPRISING BUPRENORPHINE
25
Patent #:
10273244
Issue Dt:
04/30/2019
Application #:
15750128
Filing Dt:
02/02/2018
Publication #:
US20180222918
Pub Dt:
08/09/2018
Title:
SUBSTITUTED HEXAHYDROPYRROLO[3,4-b]PYRROLES AND HEXAHYDROCYCLOPENTA[c]PYRROLES AS DOPAMINE RECEPTOR MODULATORS
26
Patent #:
10558394
Issue Dt:
02/11/2020
Application #:
15820048
Filing Dt:
11/21/2017
Publication #:
US20180157440
Pub Dt:
06/07/2018
Title:
INJECTABLE FLOWABLE COMPOSITION COMPRISING BUPRENORPHINE
27
Patent #:
NONE
Issue Dt:
Application #:
15847548
Filing Dt:
12/19/2017
Publication #:
US20180243292
Pub Dt:
08/30/2018
Title:
SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS
28
Patent #:
10198218
Issue Dt:
02/05/2019
Application #:
15857507
Filing Dt:
12/28/2017
Publication #:
US20180121137
Pub Dt:
05/03/2018
Title:
INJECTABLE FLOWABLE COMPOSITION COMPRISING BUPRENORPHINE
29
Patent #:
10376590
Issue Dt:
08/13/2019
Application #:
15858525
Filing Dt:
12/29/2017
Publication #:
US20180154001
Pub Dt:
06/07/2018
Title:
SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUND
30
Patent #:
10239870
Issue Dt:
03/26/2019
Application #:
15975466
Filing Dt:
05/09/2018
Publication #:
US20180282318
Pub Dt:
10/04/2018
Title:
DOPAMINE D3 RECEPTOR ANTAGONISTS
31
Patent #:
10517864
Issue Dt:
12/31/2019
Application #:
16016186
Filing Dt:
06/22/2018
Publication #:
US20190022085
Pub Dt:
01/24/2019
Title:
SUSTAINED-RELEASE BUPRENORPHINE SOLUTIONS
32
Patent #:
10646484
Issue Dt:
05/12/2020
Application #:
16016250
Filing Dt:
06/22/2018
Publication #:
US20180360821
Pub Dt:
12/20/2018
Title:
METHODS TO TREAT OPIOID USE DISORDER
33
Patent #:
11478407
Issue Dt:
10/25/2022
Application #:
16041170
Filing Dt:
07/20/2018
Publication #:
US20190380909
Pub Dt:
12/19/2019
Title:
SYRINGE SYSTEM
34
Patent #:
10406160
Issue Dt:
09/10/2019
Application #:
16044259
Filing Dt:
07/24/2018
Publication #:
US20180325905
Pub Dt:
11/15/2018
Title:
SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
35
Patent #:
10654842
Issue Dt:
05/19/2020
Application #:
16261206
Filing Dt:
01/29/2019
Publication #:
US20190300514
Pub Dt:
10/03/2019
Title:
DOPAMINE D3 RECEPTOR ANTAGONIST COMPOUNDS
36
Patent #:
10584135
Issue Dt:
03/10/2020
Application #:
16292110
Filing Dt:
03/04/2019
Publication #:
US20190194225
Pub Dt:
06/27/2019
Title:
SUBSTITUTED 3,6-DIAZABICYCLO[3.2.0]HEPTANES
Assignor
1
INDIVIOR UK LIMITED
Exec Dt:
05/21/2019
Assignee
1
INDIVIOR UK LIMITED
THE CHAPLEO BUILDING HENRY BOOT WAY
PRIORY PARK
HULL, UNITED KINGDOM HU4 7DY
Correspondence name and address
MINTZ LEVIN
ONE FINANCIAL CENTER
BOSTON, MA 02111

Search Results as of: 05/29/2024 06:21 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT